310 related articles for article (PubMed ID: 17148780)
1. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
3. Dried leaf extract of Olea europaea ameliorates islet-directed autoimmunity in mice.
Cvjetićanin T; Miljković D; Stojanović I; Dekanski D; Stosić-Grujicić S
Br J Nutr; 2010 May; 103(10):1413-24. PubMed ID: 20025835
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
5. In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models.
Stojanovic I; Cuzzocrea S; Mangano K; Mazzon E; Miljkovic D; Wang M; Donia M; Al Abed Y; Kim J; Nicoletti F; Stosic-Grujicic S; Claesson M
Clin Immunol; 2007 Jun; 123(3):311-23. PubMed ID: 17449326
[TBL] [Abstract][Full Text] [Related]
6. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
7. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
Augstein P; Elefanty AG; Allison J; Harrison LC
Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
[TBL] [Abstract][Full Text] [Related]
9. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
10. Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.
Cvetkovic I; Al-Abed Y; Miljkovic D; Maksimovic-Ivanic D; Roth J; Bacher M; Lan HY; Nicoletti F; Stosic-Grujicic S
Endocrinology; 2005 Jul; 146(7):2942-51. PubMed ID: 15790730
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes.
Stosic-Grujicic SD; Miljkovic DM; Cvetkovic ID; Maksimovic-Ivanic DD; Trajkovic V
J Autoimmun; 2004 Jun; 22(4):267-76. PubMed ID: 15120750
[TBL] [Abstract][Full Text] [Related]
12. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice.
Stosić-Grujicić S; Cvjetićanin T; Stojanović I
Mol Immunol; 2009 Nov; 47(1):79-86. PubMed ID: 19211146
[TBL] [Abstract][Full Text] [Related]
13. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
Rothe H; O'Hara RM; Martin S; Kolb H
Diabetologia; 1997 Jun; 40(6):641-6. PubMed ID: 9222642
[TBL] [Abstract][Full Text] [Related]
14. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE).
Shehata AM; Quintanilla-Fend L; Bettio S; Singh CB; Ammon HP
Phytomedicine; 2011 Sep; 18(12):1037-44. PubMed ID: 21831620
[TBL] [Abstract][Full Text] [Related]
15. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct.
Nicoletti F; Di Marco R; Papaccio G; Conget I; Gomis R; Bernardini R; Sims JE; Shoenfeld Y; Bendtzen K
Eur J Immunol; 2003 Aug; 33(8):2278-86. PubMed ID: 12884303
[TBL] [Abstract][Full Text] [Related]
16. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice.
Suarez-Pinzon WL; Mabley JG; Strynadka K; Power RF; Szabó C; Rabinovitch A
J Autoimmun; 2001 Jun; 16(4):449-55. PubMed ID: 11437493
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
19. Preventive effects of andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance.
Zhang C; Gui L; Xu Y; Wu T; Liu D
Int Immunopharmacol; 2013 Aug; 16(4):451-6. PubMed ID: 23707775
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes in mice by inhibition of proinflammatory cytokines.
Amirshahrokhi K; Ghazi-Khansari M
Cytokine; 2012 Nov; 60(2):522-7. PubMed ID: 22901832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
